Today: 10 April 2026
Micron stock price jumps nearly 8% as $1.8 billion Taiwan fab deal and Stifel target lift MU
20 January 2026
1 min read

Micron stock price jumps nearly 8% as $1.8 billion Taiwan fab deal and Stifel target lift MU

New York, Jan 20, 2026, 09:33 EST — Regular session

  • Micron shares surged nearly 8% in early trading, driven by investor attention on memory supply.
  • The move follows a $1.8 billion plan to buy a Taiwan fab and a new target raise from Stifel.
  • Deal approvals and the upcoming earnings report are on traders’ radar for clues about DRAM and HBM.

Micron Technology Inc (Nasdaq: MU) shares surged roughly 7.8% to $362.75 in early New York trading Tuesday, climbing $26.12 from the previous close and briefly touching $362.84. The rally came on the back of Micron’s announcement to expand capacity in Taiwan, coupled with new price-target upgrades from Wall Street analysts.

Memory’s back as a bottleneck, plain and simple. Investors aren’t just betting on growth—they’re pricing in the risk of shortages. The focus is on high-bandwidth memory, the key component for AI servers, since its supply can tighten fast and steer the whole market’s direction.

Micron announced it will acquire Powerchip Semiconductor Manufacturing Corp’s P5 fab in Tongluo, Miaoli County, Taiwan, for $1.8 billion in cash. The deal is expected to finalize by Q2 2026, pending regulatory approval. Micron aims to ramp up DRAM wafer production at the site by the second half of 2027.

Stifel’s Brian Chin bumped his price target on Micron to $360 from $300, maintaining a Buy rating following the acquisition news. He said he’s still “upbeat” on the tight memory market well into fiscal 2026. TipRanks

Micron produces DRAM, the primary working memory found in servers and PCs, alongside NAND flash used in storage devices. The company also manufactures high-bandwidth memory (HBM), a stacked DRAM variant designed to sit near AI processors for faster data transfer.

A letter of intent doesn’t seal the deal, but it lays out a clear route to boosting capacity in a sector where new facilities often take years to come online. The cleanroom area at the Taiwan site is key—it’s the controlled environment essential for operating the equipment that manufactures chips.

Still, the benefits won’t show up right away. Capacity hitting in 2027 does little to ease short-term supply concerns, leaving the market vulnerable to any demand fluctuations.

Memory investors know the drill. If major cloud clients cut back spending or competitors ramp up capacity faster than anticipated, prices can drop sharply — and a stock that’s rallied this hard can lose those gains just as quickly.

Micron entered Tuesday riding a solid streak, its shares having climbed roughly 27% in 2026, per Investors.com. That kind of momentum tends to magnify the impact of any news, whether positive or slightly underwhelming.

Investors are now zeroing in on the Taiwan deal’s progress — from filings and regulatory hurdles to updates on the closing schedule. They’ll also watch Micron’s upcoming earnings report for clues on pricing and supply control. According to market calendars like Yahoo Finance, Micron’s next earnings call is expected around March 18.

Stock Market Today

  • Morgan Stanley Raises Price Target for Regeneron Pharmaceuticals STOCK
    April 10, 2026, 12:29 PM EDT. Morgan Stanley increased its price target for Regeneron Pharmaceuticals (NASDAQ:REGN) from $769 to $796, indicating a potential 6.36% upside. The biopharmaceutical stock is rated "equal weight" by Morgan Stanley. Other analysts show mixed views: Piper Sandler rates it "overweight" with an $875 target, while Guggenheim and JPMorgan raised their targets to $975 and $950 respectively, maintaining buy ratings. Regeneron's average analyst rating is "Moderate Buy" with a target near $812. The stock dropped 2.5% to $748.42 on Friday, below the 50-day average of $767.27. The company reported strong Q4 earnings with EPS of $11.44, beating estimates, and revenue grew 2.5% year-over-year to $3.88 billion. Market cap stands at $79.12 billion with a P/E ratio of 17.99.

Latest article

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 12:29 PM EDT Morgan Stanley Raises Price Target for Regeneron Pharmaceuticals STOCK April 10, 2026, 12:29 PM EDT. Morgan Stanley increased its price target for Regeneron Pharmaceuticals (NASDAQ:REGN) from $769 to $796, indicating a potential 6.36% upside. The biopharmaceutical stock is rated "equal weight" by Morgan Stanley. Other analysts show mixed views: Piper Sandler rates it "overweight" with an $875 target, while Guggenheim and JPMorgan raised their targets to $975 and $950 respectively, maintaining buy ratings. Regeneron's average analyst rating is "Moderate Buy" with a target near $812.
MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
Apple stock slips early as tariff jitters weigh on tech; analysts point to iPhone demand
Previous Story

Apple stock slips early as tariff jitters weigh on tech; analysts point to iPhone demand

Microsoft stock price today: MSFT ticks up on Bristol Myers AI lung-cancer imaging deal
Next Story

Microsoft stock price today: MSFT ticks up on Bristol Myers AI lung-cancer imaging deal

Go toTop